Search results for "Anesthesia"

showing 10 items of 2277 documents

Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy.

2003

Abstract Background In primary pulmonary hypertension, aerosolized prostanoids selectively reduce pulmonary vascular resistance and improve right ventricular function. In this study, hemodynamic effects of inhaled iloprost, a stable prostacyclin analogue, were evaluated in patients with chronic thromboembolic pulmonary hypertension (CTEPH) before and early after pulmonary thromboendarterctomy (PTE). Methods Ten patients (mean age 49 years old [32 to 70 years old], New York Heart Association functional class III and IV) received a dose of 33 μg aerosolized iloprost immediately before surgery (T1), after intensive care unit admission (T2), and 12-hours postoperatively (T3). Effects on pulmona…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_treatmentHypertension PulmonaryVasodilator AgentsHemodynamicsEndarterectomymedicine.arteryAdministration InhalationPreoperative CaremedicineHumansIloprostPostoperative PeriodEndarterectomyAgedPulmonary thromboendarterectomybusiness.industryRespiratory diseaseMiddle Agedmedicine.diseasePulmonary hypertensionmedicine.anatomical_structureAnesthesiaPulmonary arteryChronic DiseaseVascular resistanceSurgeryFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismIloprostmedicine.drugThe Annals of thoracic surgery
researchProduct

Cardiovascular Events in Moderately to Severely Obese Obstructive Sleep Apnea Patients on Positive Airway Pressure Therapy.

2016

<b><i>Background:</i></b> In moderately to severely obese patients with obstructive sleep apnea (OSA), the effects of long-term positive airway pressure (PAP) treatment on cardiovascular risk are poorly defined. <b><i>Purpose:</i></b> To assess the effect of continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) on the occurrence of cardiovascular events in obese OSA patients. <b><i>Methods:</i></b> We performed a noninterventional observational study in obese OSA patients recruited between 2007 and 2010 at the Sleep Center, University of Grenoble, treated with CPAP or NIV, and followed for 5.6 year…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_treatmentMyocardial Infarctionmacromolecular substancesComorbiditySettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineSleep and breathingRisk FactorsSeverity of illnessPositive airway pressuremedicineMyocardial RevascularizationHumansContinuous positive airway pressureMyocardial infarctionAngina UnstableObesityAcute Coronary SyndromeStrokeAgedSleep-disordered breathing · Longitudinal studies · Continuous positive airway pressure · Noninvasive ventilation · PrognosisSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseObesityrespiratory tract diseasesObstructive sleep apneaStroke030228 respiratory systemCardiovascular DiseasesAnesthesiaFemalebusinessRespiration; international review of thoracic diseases
researchProduct

Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Ge…

2021

Summary Background Previous studies indicate that isoflurane could be useful for the sedation of patients in the intensive care unit (ICU), but prospective studies evaluating isoflurane's efficacy have been small. The aim of this study was to test whether the sedation with isoflurane was non-inferior to sedation with propofol. Methods This phase 3, randomised, controlled, open-label non-inferiority trial evaluated the efficacy and safety of up to 54 h of isoflurane compared with propofol in adults (aged ≥18 years) who were invasively ventilated in ICUs in Germany (21 sites) and Slovenia (three sites). Patients were randomly assigned (1:1) to isoflurane inhalation via the Sedaconda anaesthet…

Pulmonary and Respiratory MedicineAdultSedationPopulationSlovenialaw.inventionlawIntensive careGermanyClinical endpointMedicineHumansHypnotics and SedativesProspective StudieseducationProspective cohort studyPropofolAnestheticseducation.field_of_studyIsofluranebusiness.industryIntensive care unitRespiration ArtificialIntensive Care UnitsIsofluraneAnesthesiamedicine.symptombusinessPropofolmedicine.drugThe Lancet. Respiratory medicine
researchProduct

Revising old principles of inhaled treatment in new fixed combinations for asthma.

2015

The major influencing factors on persistent asthma control are the selected treatment(s), the drug delivery route and patient's adherence to therapy, together with the influence of lifestyle (i.e. sedentary habit), comorbid conditions and specific asthma phenotypes. Inhaled corticosteroids (ICS) in combination with a long-acting β2-agonist (LABA) are the gold standard for management of persistent asthma, with maximal local targeting and minimal systemic side effects. Several innovative inhaler devices have been developed for effective local drug administration and good patient compliance to therapy. Recently, a new ICS/LABA fixed combination, formulated with fluticasone propionate (FP) and …

Pulmonary and Respiratory MedicineAdultmedicine.medical_specialtyDoseAdolescentmedicine.drug_classSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionateFluticasone propionatelaw.inventionMedication AdherenceRandomized controlled triallawInternal medicineDrug CombinationFormoterol FumarateAdministration InhalationmedicineCorticosteroidAnti-Asthmatic AgentHumansPharmacology (medical)Anti-Asthmatic AgentsBronchodilator AgentAsthmabusiness.industryInhalerMedicine (all)Biochemistry (medical)medicine.diseaseAsthmaDiscontinuationInhaled treatmentBronchodilator AgentsDrug CombinationsAnesthesiaCorticosteroidFluticasoneFormoterol Fumaratebusinessmedicine.drugHumanPulmonary pharmacologytherapeutics
researchProduct

The role of lung inflation in airway hyperresponsiveness and in asthma

2004

Airway hyperresponsiveness (AHR) is a fundamental phenomenon in asthma that can explain many aspects of the clinical manifestations of the disease. Several theories on the mechanisms of AHR have been proposed, but the true nature of this problem is yet to be defined. During the past decade, the role of lung inflation in airway physiology and its relationship to AHR have attracted major attention. Deep inspirations are known to exert strong beneficial effects on the airways of healthy humans. These effects appear to be of dual nature: bronchoprotective and bronchodilatory. The bronchoprotective effect of deep inspiration is lost in asthma, even in mild disease. It is also lost in individuals…

Pulmonary and Respiratory MedicineAllergyBronchoconstrictionImmunologyAirway hyperresponsivenessDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioSeverity of Illness IndexBronchodilationmedicineImmunology and AllergyHumansLungAsthmaLungbusiness.industryrespiratory systemAirway obstructionmedicine.diseaseAsthmarespiratory tract diseasesAirway Obstructionmedicine.anatomical_structureAnesthesiaImmunologyasthma lung function.Bronchial HyperreactivitybusinessAirway
researchProduct

High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations

1998

The antifibrinolytic efficacy of a high-dose regimen of epsilon-aminocaproic acid (epsilon-ACA) was compared with aprotinin in first-time coronary operations.In a prospective, double-blinded, randomized study, 20 patients received high-dose epsilon-ACA (10 g both as a loading and cardiopulmonary bypass priming dose, 2.5 g/h until 4 hours after protamine), and another 20 patients received aprotinin (2 x 10(6) KIU [280 mg] for loading and priming, 0.5 x 10(6) KIU/h [70 mg/h]). Ten untreated patients served as controls.Both agents reduced postoperative levels of thrombin/antithrombin III complexes, D-dimers, fibrin degradation products, free plasma hemoglobin (epsilon-ACA versus aprotinin, p =…

Pulmonary and Respiratory MedicineAntifibrinolyticmedicine.drug_classHematocritHemostaticsFibrinlaw.inventionBlood Transfusion AutologousAprotininThrombinDouble-Blind MethodlawMyocardial RevascularizationmedicineCardiopulmonary bypassHumansBlood TransfusionAprotininProspective StudiesBlood CoagulationCardiopulmonary Bypassbiologymedicine.diagnostic_testbusiness.industryFibrinolysisAntithrombinAntifibrinolytic AgentsHematocritAnesthesiaAminocaproic Acidbiology.proteinSurgeryAminocaproic acidCardiology and Cardiovascular Medicinebusinessmedicine.drugThe Annals of Thoracic Surgery
researchProduct

Intraoperative neuroprotective drugs without beneficial effects? Results of the German Registry for Acute Aortic Dissection Type A (GERAADA).

2013

OBJECTIVES: Cerebral protection during acute aortic dissection Type A (AADA) surgery may be affected by perfusion strategies and ischaemic protective drugs. METHODS: We analysed the impact of intraoperative barbiturate, steroid and mannitol use and adjunctive cerebral perfusion (CP), on 30-day mortality and new postoperative mortality-corrected permanent neurological dysfunction (PNDmc) in the German Registry for Acute Aortic Dissection Type A. RESULTS: Two thousand one hundred and thirty-seven AADA patients were registered over a 4-year period. The overall 30-day mortality was 16.9%, and the overall rate of PNDmc was 10.0%. A total of 48% of patients received no neuroprotective drugs (cont…

Pulmonary and Respiratory MedicineAortic archMalemedicine.drug_classOperative TimePostoperative ComplicationsRisk Factorsmedicine.arteryGermanymedicineHumansMannitolCerebral perfusion pressureCardiac Surgical ProceduresMortalityAgedAortic dissectionChi-Square DistributionIntraoperative Carebusiness.industryMortality rateGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseAortic AneurysmAortic DissectionNeuroprotective AgentsBarbiturateAnesthesiaBarbituratesSurgeryFemaleSteroidsMannitolCardiology and Cardiovascular MedicinebusinessPerfusionmedicine.drugEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Analysis of atelectasis, ventilated, and hyperinflated lung during mechanical ventilation by dynamic CT.

2005

Study objective: To study the dynamics of lung compartments by dynamic CT (dCT) imaging during uninterrupted pressure-controlled ventilation (PCV) and different positive end-expiratory pressure (PEEP) settings in healthy and damaged lungs. Design: Experimental animal investigation. Setting: Experimental animal facility of a university department. Interventions: In seven anesthetized pigs, static inspiratory pressure volume curves were obtained to identify the individual lower inflection point (LIP) before and after saline solution lung lavage. During PCV, PEEP was adjusted 5 millibars (mbar) below the individually determined LIP (LIP - 5), at the LIP, and 5 mbar above the LIP (LIP + 5). Mea…

Pulmonary and Respiratory MedicineArtificial ventilationARDSPulmonary AtelectasisSwinemedicine.medical_treatmentAtelectasisCritical Care and Intensive Care MedicinePositive-Pressure RespirationmedicineImage Processing Computer-AssistedTidal VolumeAnimalsTherapeutic IrrigationLungPositive end-expiratory pressureMechanical ventilationRespiratory Distress SyndromeLungbusiness.industryPulmonary Gas ExchangeHemodynamicsrespiratory systemCarbon Dioxidemedicine.diseaseRespiration Artificialrespiratory tract diseasesOxygenPulmonary Alveolimedicine.anatomical_structureAnesthesiaBreathingPulmonary shuntmedicine.symptomCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedChest
researchProduct

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial …

2012

The inhaled corticosteroid fluticasone propionate (fluticasone) and the long-acting β₂ agonist formoterol fumarate (formoterol) have been combined in a single aerosol inhaler fluticasone/formoterol (flutiform(®)). This study compared the efficacy and safety of fluticasone/formoterol with the combination product budesonide/formoterol (Symbicort(®) Turbohaler(®)).A randomized, double-blind, double-dummy, multicenter, Phase 3 study comprising a 7- (± 3) day screening, 2-4-week run-in, and 12-week treatment periods. Patients aged ≥ 12 years with moderate to severe persistent asthma for ≥ 6 months before screening and forced expiratory volume in one second (FEV₁) 50-80% predicted and ≥ 15% rever…

Pulmonary and Respiratory MedicineBudesonideAdultMaleAdolescentFluticasone propionateYoung AdultDouble-Blind Methodimmune system diseasesForced Expiratory VolumeFormoterol FumarateAdministration InhalationImmunology and AllergyMedicineHumansBudesonideFluticasoneAgedbusiness.industryInhalerDry Powder Inhalersrespiratory systemMiddle AgedAsthmarespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsBudesonide/formoterolEthanolaminesAnesthesiaPediatrics Perinatology and Child HealthSalbutamolFluticasoneFormoterol FumarateFemaleFormoterolbusinesshormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient.

2003

The rational choice of an inhalation device is a cornerstone in the effective management of asthma and COPD. In this publication, we describe the development of a new system, the Inhalation Manager, which, for the first time, offers the possibility to assess the entire inhalation maneuver of patients using original devices under everyday conditions. So far the Inhalation Manager allows the measurement of inspiratory maneuvers of patients through placebo inhalation devices of the most common breath-actuated CFC-free inhalers in the market for the three main glucocorticosteroids Budesonide [Turbohaler (TH), dry powder inhaler (DPI)], Beclomethasone dipropionate [Autohaler (AH), breath-actuate…

Pulmonary and Respiratory MedicineBudesonideAdultMaleInhalationAdolescentbusiness.industryInhalerNebulizers and VaporizersBeclometasone dipropionateMiddle AgedMetered-dose inhalerDry-powder inhalerFluticasone propionateDrug Delivery SystemsAnesthesiamedicineHumansPharmacology (medical)FemaleParticle SizebusinessFluticasonemedicine.drugJournal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
researchProduct